Cognoptix disclosed at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting the strong results of a multi-site clinical trial of its SAPPHIRE II eye test, which is designed to identify Alzheimer’s ...
Tags: Cognoptix Eye, Alzheimer's Disease
The 5th International Conference on Clinical Trials for Alzheimer's Disease (CTAD) will examine the phase 3 treatment trials of Alzheimer's Disease (AD) and also analyze the results to develop current and new drugs to tackle AD. The ...
Tags: CTAD, AD, Alzheimer's Disease